Skip to main content
Journal cover image

Perspectives on the Barrier to Resistance for Dolutegravir + Lamivudine, a Two-Drug Antiretroviral Therapy for HIV-1 Infection

Publication ,  Journal Article
Boffito, M; Waters, L; Cahn, P; Paredes, R; Koteff, J; Van Wyk, J; Vincent, T; Demarest, J; Adkison, K; Quercia, R
Published in: AIDS Research and Human Retroviruses
January 1, 2020

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

AIDS Research and Human Retroviruses

DOI

EISSN

1931-8405

ISSN

0889-2229

Publication Date

January 1, 2020

Volume

36

Issue

1

Start / End Page

13 / 18

Publisher

Mary Ann Liebert Inc

Related Subject Headings

  • Virology
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Boffito, M., Waters, L., Cahn, P., Paredes, R., Koteff, J., Van Wyk, J., … Quercia, R. (2020). Perspectives on the Barrier to Resistance for Dolutegravir + Lamivudine, a Two-Drug Antiretroviral Therapy for HIV-1 Infection. AIDS Research and Human Retroviruses, 36(1), 13–18. https://doi.org/10.1089/aid.2019.0171
Boffito, Marta, Laura Waters, Pedro Cahn, Roger Paredes, Justin Koteff, Jean Van Wyk, Tia Vincent, James Demarest, Kimberly Adkison, and Romina Quercia. “Perspectives on the Barrier to Resistance for Dolutegravir + Lamivudine, a Two-Drug Antiretroviral Therapy for HIV-1 Infection.” AIDS Research and Human Retroviruses 36, no. 1 (January 1, 2020): 13–18. https://doi.org/10.1089/aid.2019.0171.
Boffito M, Waters L, Cahn P, Paredes R, Koteff J, Van Wyk J, et al. Perspectives on the Barrier to Resistance for Dolutegravir + Lamivudine, a Two-Drug Antiretroviral Therapy for HIV-1 Infection. AIDS Research and Human Retroviruses. 2020 Jan 1;36(1):13–8.
Boffito, Marta, et al. “Perspectives on the Barrier to Resistance for Dolutegravir + Lamivudine, a Two-Drug Antiretroviral Therapy for HIV-1 Infection.” AIDS Research and Human Retroviruses, vol. 36, no. 1, Mary Ann Liebert Inc, Jan. 2020, pp. 13–18. Crossref, doi:10.1089/aid.2019.0171.
Boffito M, Waters L, Cahn P, Paredes R, Koteff J, Van Wyk J, Vincent T, Demarest J, Adkison K, Quercia R. Perspectives on the Barrier to Resistance for Dolutegravir + Lamivudine, a Two-Drug Antiretroviral Therapy for HIV-1 Infection. AIDS Research and Human Retroviruses. Mary Ann Liebert Inc; 2020 Jan 1;36(1):13–18.
Journal cover image

Published In

AIDS Research and Human Retroviruses

DOI

EISSN

1931-8405

ISSN

0889-2229

Publication Date

January 1, 2020

Volume

36

Issue

1

Start / End Page

13 / 18

Publisher

Mary Ann Liebert Inc

Related Subject Headings

  • Virology
  • 1103 Clinical Sciences